The presence of anti-Thyroglobulin serum autoantibodies (TgAb) has been reported as an independent risk factor for papillary thyroid carcinoma (PTC), with increase in TgAb prevalence in subjects with PTC and with influence on the prognosis [6,7,8,9]. This evidence concerns the gene TG and thyroid gland papillary carcinoma.